ROYAL BANK OF CANADA - CADENCE PHARMACEUTICALS INC ownership

CADENCE PHARMACEUTICALS INC's ticker is CADX and the CUSIP is 12738T100. A total of 100 filers reported holding CADENCE PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CADENCE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2013$6,000
-80.6%
1,000
-77.7%
0.00%
Q2 2013$31,0004,4850.00%
Other shareholders

There were no reported owners of CADENCE PHARMACEUTICALS INC in Q4 2013.

NameSharesValueWeighting ↓
View complete list of CADENCE PHARMACEUTICALS INC shareholders